A detailed history of Clari Vest Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 42,040 shares of ABBV stock, worth $7.57 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
42,040
Previous 42,040 -0.0%
Holding current value
$7.57 Million
Previous $7.21 Million 15.15%
% of portfolio
0.83%
Previous 0.76%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $354,469 - $413,940
-2,290 Reduced 5.17%
42,040 $7.21 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $16.4 Million - $18.7 Million
-102,813 Reduced 69.87%
44,330 $8.07 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $3.44 Million - $3.88 Million
-25,022 Reduced 14.53%
147,143 $22.8 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $1.88 Million - $2.18 Million
-14,066 Reduced 7.55%
172,165 $25.7 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $4.57 Million - $5.69 Million
-34,500 Reduced 15.63%
186,231 $25.1 Million
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $1.29 Million - $1.48 Million
-8,906 Reduced 3.88%
220,731 $35.2 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $822,944 - $986,926
-5,950 Reduced 2.53%
229,637 $37.1 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $1.88 Million - $2.16 Million
-14,000 Reduced 5.61%
235,587 $31.6 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $1.49 Million - $1.9 Million
-10,852 Reduced 4.17%
249,587 $38.2 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $1.36 Million - $1.69 Million
10,300 Added 4.12%
260,439 $42.2 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $703,559 - $890,205
-6,549 Reduced 2.55%
250,139 $33.9 Million
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $694,047 - $787,847
-6,523 Reduced 2.48%
256,688 $27.7 Million
Q2 2021

Aug 09, 2021

SELL
$105.21 - $117.21 $1.43 Million - $1.59 Million
-13,592 Reduced 4.91%
263,211 $29.6 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $3.04 Million - $3.35 Million
-29,720 Reduced 9.7%
276,803 $30 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $3.9 Million - $5.26 Million
-48,407 Reduced 13.64%
306,523 $32.8 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $1.09 Million - $1.28 Million
-12,681 Reduced 3.45%
354,930 $31.1 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $5.25 Million - $7.02 Million
-71,498 Reduced 16.28%
367,611 $36.1 Million
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $1.93 Million - $2.93 Million
-29,949 Reduced 6.38%
439,109 $33.5 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $2.91 Million - $3.64 Million
-40,301 Reduced 7.91%
469,058 $41.5 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $7.25 Million - $8.72 Million
115,106 Added 29.2%
509,359 $38.6 Million
Q2 2019

Aug 16, 2019

SELL
$65.7 - $83.98 $1.78 Million - $2.28 Million
-27,154 Reduced 6.44%
394,253 $28.7 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $8.77 Million - $10.3 Million
-113,677 Reduced 21.24%
421,407 $34 Million
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $2.04 Million - $2.51 Million
-26,151 Reduced 4.66%
535,084 $49.3 Million
Q3 2018

Nov 07, 2018

SELL
$88.91 - $98.84 $3.51 Million - $3.9 Million
-39,491 Reduced 6.57%
561,235 $53.1 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $4.09 Million - $4.84 Million
-45,586 Reduced 7.05%
600,726 $55.7 Million
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $1.45 Million - $1.95 Million
-15,801 Reduced 2.39%
646,312 $61.2 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $27.5 Million - $30.2 Million
307,548 Added 86.74%
662,113 $64 Million
Q3 2017

Nov 07, 2017

SELL
$69.85 - $89.22 $1.01 Million - $1.29 Million
-14,408 Reduced 3.9%
354,565 $31.5 Million
Q2 2017

Nov 20, 2017

BUY
N/A
368,973
368,973 $26.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.